| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |